Standout Papers
- Tyrosine Kinase Inhibition: An Approach to Drug Development (1995)
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor (1996)
- Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells (2001)
- Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors (1989)
- Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors (1988)
Immediate Impact
22 by Nobel laureates 28 from Science/Nature 83 standout
Citing Papers
The JAK-STAT pathway at 30: Much learned, much more to do
2022 Standout
Through Scalp and Skull NIR‐II Photothermal Therapy of Deep Orthotopic Brain Tumors with Precise Photoacoustic Imaging Guidance
2018 Standout
Works of Aviv Gazit being referenced
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteases
1998
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
1996 StandoutNature
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aviv Gazit | 5250 | 3232 | 1065 | 1265 | 99 | 9.6k | |
| Richard A. Rifkind | 11335 | 2885 | 882 | 1010 | 123 | 14.2k | |
| Linda S. Steelman | 7451 | 3301 | 593 | 982 | 111 | 11.0k | |
| Peter E. Czabotar | 8718 | 2071 | 605 | 2109 | 97 | 11.5k | |
| Shinichi Kitada | 7529 | 3170 | 412 | 2746 | 112 | 11.7k | |
| Lubor Borsig | 3245 | 2089 | 493 | 1620 | 98 | 6.9k | |
| Stevan R. Hubbard | 9537 | 2502 | 580 | 1354 | 89 | 14.2k | |
| Alex N. Bullock | 5941 | 2744 | 852 | 610 | 106 | 8.4k | |
| Surender Kharbanda | 12025 | 3972 | 815 | 2212 | 189 | 15.4k | |
| Jan Hofsteenge | 5249 | 1077 | 806 | 862 | 115 | 8.5k | |
| Christian Rommel | 7186 | 1701 | 392 | 2075 | 87 | 10.0k |
All Works
Loading papers...